LCN2 and Sepsis: The utility of NGAL as a biomarker of renal impairment has been tested in various clinical situations, in both adult and pediatric populations: critically ill patients [3], after cardiac surgery [16-19], after contrast agent administration [20], sepsis [21], trauma patients [22].